PTX — Prescient Therapeutics Share News
0.000.00%
Last trade - 00:00- AU$56.78m
- AU$47.98m
- AU$0.14m
Australia Stock Exchange release from PRESCIENT THERAP : Capital Structure Update - Expiry of Unlisted Options
Australia Stock Exchange release from PRESCIENT THERAP : Appendix 4D and Half Year Financial Report
Australia Stock Exchange release from PRESCIENT THERAP : PRE_NR Ends: 17:09:37
Australia Stock Exchange release from PRESCIENT THERAP : December 2020 Quarterly Update and Appendix 4C
Australia Stock Exchange release from PRESCIENT THERAP : PRE_NR Ends: 09:59:37
Australia Stock Exchange release from PRESCIENT THERAP : PRE_NR Ends: 09:32:10
Australia Stock Exchange release from PRESCIENT THERAP : PTX announces 3 next-gen CAR-T programs with OmniCAR
Australia Stock Exchange release from PRESCIENT THERAP : Appendix 3G
Australia Stock Exchange release from PRESCIENT THERAP : Change of Director's Interest Notices x4
Australia Stock Exchange release from PRESCIENT THERAP : Leading International Blood Cancer Specialist Joins PTX SAB
Australia Stock Exchange release from PRESCIENT THERAP : Appendix 3G
Australia Stock Exchange release from PRESCIENT THERAP : Issue of Unlisted Options
Brief: Prescient Therapeutics Extends Covid-19 Testing Program With Doherty Institute
Australia Stock Exchange release from PRESCIENT THERAP : PTX Extends COVID-19 Testing Program with Doherty Institute
Australia Stock Exchange release from PRESCIENT THERAP : Amendment of Results of Annual General Meeting
Australia Stock Exchange release from PRESCIENT THERAP : Constitution
Australia Stock Exchange release from PRESCIENT THERAP : Results of Annual General Meeting
Australia Stock Exchange release from PRESCIENT THERAP : AGM Presentation
Australia Stock Exchange release from PRESCIENT THERAP : PRE_NR Ends: 14:00:21